Stay updated on Olaparib in BRCA Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Olaparib in BRCA Ovarian Cancer Clinical Trial page.

Latest updates to the Olaparib in BRCA Ovarian Cancer Clinical Trial page
- Check4 days agoChange DetectedThe site version label was updated from v3.6.6 to v3.7.0, indicating a platform update that does not alter the trial information shown on the page.SummaryDifference0.0%

- Check18 days agoChange DetectedThe page's revision line now shows Revision: v3.6.6, replacing Revision: v3.6.5 in the metadata/footer. This reflects a minor version update in the page's maintenance metadata.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check40 days agoChange DetectedThe revision label on the page was updated from v3.6.4 to v3.6.5, indicating a newer build of the site. This is a maintenance/update rather than a change to study content or user-facing features.SummaryDifference0.0%

- Check47 days agoChange DetectedThe study record now displays the most recent update dates, indicating routine maintenance to refresh the record. These changes are metadata about maintenance rather than substantive updates to the study design, results, or eligibility criteria.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4, reflecting a small update to the page metadata.SummaryDifference0.0%

- Check75 days agoChange DetectedRevision bumped from v3.6.2 to v3.6.3 on the page, indicating a software update. The study content and visible information for NCT01874353 appear unchanged.SummaryDifference0.0%

Stay in the know with updates to Olaparib in BRCA Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaparib in BRCA Ovarian Cancer Clinical Trial page.